ALK Fusion Variant 3a/b, Concomitant Mutations, and High PD-L1 Expression Were Associated with Unfavorable Clinical Response to Second-Generation ALK TKIs in Patients with Advanced ALK-rearranged Non-Small Cell Lung Cancer (GASTO 1061)
LUNG CANCER（2022）
关键词
ALK-rearranged NSCLC,ALK fusion variants,Concomitant mutations,PD-L1 expression,Tyrosine kinase inhibitors (TKIs)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要